IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.545
AS - Asia 1.732
EU - Europa 992
SA - Sud America 248
AF - Africa 226
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.468
SG - Singapore 913
CN - Cina 465
IT - Italia 325
BR - Brasile 204
IE - Irlanda 191
RU - Federazione Russa 152
CI - Costa d'Avorio 147
VN - Vietnam 108
KR - Corea 85
DE - Germania 71
GB - Regno Unito 52
UA - Ucraina 49
CA - Canada 48
IN - India 42
NL - Olanda 35
SN - Senegal 25
FI - Finlandia 23
BJ - Benin 22
HK - Hong Kong 22
MX - Messico 21
JP - Giappone 20
PL - Polonia 19
AR - Argentina 17
CZ - Repubblica Ceca 16
SE - Svezia 15
BD - Bangladesh 14
NG - Nigeria 14
ID - Indonesia 12
ES - Italia 11
ZA - Sudafrica 11
FR - Francia 9
IQ - Iraq 9
TR - Turchia 9
CH - Svizzera 8
CO - Colombia 6
PE - Perù 6
EC - Ecuador 5
PY - Paraguay 5
IR - Iran 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MA - Marocco 3
SA - Arabia Saudita 3
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
PK - Pakistan 1
QA - Qatar 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
Totale 5.747
Salva come PNG Salva come JPEG
Città #
Singapore 541
Santa Clara 471
Dallas 418
Dublin 191
Chandler 179
Ashburn 173
Hefei 170
Abidjan 147
Los Angeles 143
Chicago 108
Seoul 84
Beijing 76
Boardman 69
Civitanova Marche 65
Moscow 59
New York 51
Cambridge 50
Jacksonville 50
Lawrence 50
Catania 48
Ho Chi Minh City 41
Andover 38
Buffalo 37
Nanjing 28
Bremen 26
Amsterdam 25
Dakar 25
São Paulo 25
Des Moines 24
Cotonou 22
Hong Kong 21
Tokyo 20
Brooklyn 18
Hanoi 18
Lappeenranta 18
Toronto 18
Milan 17
Saint Petersburg 17
Warsaw 17
Denver 16
Wilmington 15
Abuja 14
Chennai 14
Stockholm 14
Brno 13
Poplar 13
Rome 13
San Francisco 12
Council Bluffs 11
Orem 11
Washington 11
Houston 10
Phoenix 10
Mexico City 9
Nanchang 9
Haiphong 8
London 8
Montreal 8
Ankara 7
Atlanta 7
Manchester 7
Frankfurt am Main 6
Johannesburg 6
Mumbai 6
Querétaro 6
Redwood City 6
Rio de Janeiro 6
Shenyang 6
Arequipa 5
Calgary 5
Genoa 5
Hebei 5
Messina 5
Munich 5
Palermo 5
Redondo Beach 5
San Mateo 5
Tianjin 5
Turin 5
Turku 5
Baghdad 4
Bernareggio 4
Bắc Ninh 4
Changsha 4
Columbus 4
Da Nang 4
Dhaka 4
Dong Ket 4
Misterbianco 4
Pune 4
Tehran 4
The Dalles 4
Bari 3
Bishkek 3
Boston 3
Brussels 3
Charlotte 3
Curitiba 3
Falls Church 3
Favara 3
Totale 4.012
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 100
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 96
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 94
Minor pulmonary malformations in a child 94
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 93
Lung clearance index: A new measure of late lung complications of cancer therapy in children 93
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 93
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 92
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 91
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 89
Serum YKL-40 in children with asthma 89
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 88
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 88
Biomarkers in pediatric lung diseases including cystic fibrosis 88
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 88
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 87
Lactoferrin: Cytokine modulation and application in clinical practice 87
Hypertransaminasemia in children is not always as simple as it seems 87
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 85
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 85
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 83
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 82
Cetirizine use in childhood: An update of a friendly 30-year drug 82
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 80
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 80
HMGB1 values and response to HBV vaccine in children with celiac disease 79
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 78
Exhaled breath temperature in astmatic children 76
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 76
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 75
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 75
Antihistamines: ABC for the pediatricians 74
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 73
Novel therapeutic targets for allergic airway disease in children 73
Severe Kawasaki disease in a 3-month-old patient: a case report. 72
Liver disease in Cystic Fibrosis: an update 71
Antihistamines in children and adolescents: A practical update 71
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 70
Genetic disorders of surfactant deficiency and neonatal lung disease 70
Severe disease in Cystic Fibrosis and fecal calprotectin levels 69
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 66
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 66
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 66
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 65
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 65
Lung clearance index for evaluation of late complications of cancer therapy in children 64
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 64
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 63
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 62
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 61
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 61
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 60
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 59
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 59
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 59
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 58
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 58
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 57
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 57
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 56
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 55
The immunomodulatory role of vitamin D in respiratory diseases 55
Lower airway microbiota 55
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 54
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 53
Upper and lower airways diseases in childhood 53
Type 2 inflammation in cystic fibrosis: New insights 51
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 49
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 49
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 49
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 48
Protracted bacterial bronchitis: more to know 47
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 47
Nasal microbiome in chronic rhinosinusitis 44
The role of skin infections in atopic dermatitis in children 43
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 43
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells 43
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 35
Pidotimod in allergic diseases 34
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management 29
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 20
Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis 20
Oral immunotherapy in children with allergic diseases: past, present and future 19
HMGB1 as a Biomarker of Inhaled Corticosteroid Treatment Response in Moderate-Severe Asthmatic Children: A Single Center Pilot Study 19
Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators 18
Reply to Schriever et al. 17
Efficacy of sublingual allergen-specific immunotherapy in children evaluated by the measurements of bronchial and nasal nitric oxide. Preliminary results 16
Calprotectin in cystic fibrosis: A new marker of flogosis 13
Novel biologics for the treatment of pediatric severe asthma 12
Correlation between RINT values and echocardiographic indices in pre-school children with chronic cough and wheezing 12
COVID-19 ocular manifestation in children 12
Serum levels of YKL-40 in patients with cystic fibrosis: A pilot study 12
Effectiveness of omalizumab in two children with severe vernal keratoconjunctivitis 11
Measurement of nitric oxide and assessment of airway diseases in children: An update 11
Extreme hyperferritinemia in the pediatric emergency setting: haemophagocytic lymphohistiocytosis, macrophage activation syndrome, sepsis and more 11
Three Consecutive Cases of Double Aortic Arch with Various Clinical Onset 11
Influence of early growth on childhood lung function assessed by magnetic resolution imaging and spirometry. The Generation R Study 11
Efficacy and Safety of Pidotimod in Childhood Wheezing: A Pilot Study 10
Zooming in on the ERS fellowships and the international congress 10
Plasmatic Amino Acids in Patients with Cystic Fibrosis: An Observational Study 10
Totale 5.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.625 47 188 68 112 292 310 48 33 75 148 163 141
2025/20262.632 265 330 595 366 1.056 20 0 0 0 0 0 0
Totale 5.918